Red Hat katello-headpin SAM Web Application cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Red Hat katello-headpin. This issue affects some unknown processing of the component SAM Web Application. The manipulation results in cross site scripting. This vulnerability is reported as CVE-2014-0029. The attack can be launched remotely. No exploit exists.
Details
A vulnerability classified as problematic has been found in Red Hat katello-headpin (affected version unknown). Affected is an unknown functionality of the component SAM Web Application. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Multiple cross-site scripting (XSS) vulnerabilities in the SAM web application in Red Hat katello-headpin allow remote attackers to inject arbitrary web script or HTML via unspecified parameters.
The bug was discovered 12/03/2013. The weakness was disclosed 10/16/2017 as Bug 1059433 as not defined bug report (Bugzilla). The advisory is shared for download at bugzilla.redhat.com. This vulnerability is traded as CVE-2014-0029 since 12/03/2013. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 11/25/2019). The MITRE ATT&CK project declares the attack technique as T1059.007.
The vulnerability was handled as a non-public zero-day exploit for at least 1413 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.redhat.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/03/2013 🔍12/03/2013 🔍
10/16/2017 🔍
10/16/2017 🔍
10/17/2017 🔍
11/25/2019 🔍
Sources
Vendor: redhat.comAdvisory: Bug 1059433
Status: Not defined
Confirmation: 🔍
CVE: CVE-2014-0029 (🔍)
GCVE (CVE): GCVE-0-2014-0029
GCVE (VulDB): GCVE-100-107892
Entry
Created: 10/17/2017 08:59Updated: 11/25/2019 10:21
Changes: 10/17/2017 08:59 (57), 11/25/2019 10:21 (2)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.